UBS AM
WGS icon

UBS AM’s GeneDx Holdings WGS Stock Holding History

UBS AM’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16M Sell
249,432
-9,313
-4% -$849K ﹤0.01% 970
2025
Q4 		$33.7M Buy
258,745
+227,088
+717% +$31.2M 0.01% 702
2025
Q3 		$3.41M Sell
31,657
-16,504
-34% -$1.8M ﹤0.01% 1543
2025
Q2 		$4.45M Buy
48,161
+19,937
+71% +$1.57M ﹤0.01% 1769
2025
Q1 		$2.5M Buy
28,224
+11,375
+68% +$987K ﹤0.01% 1884
2024
Q4 		$1.3M Buy
16,849
+9,202
+120% +$643K ﹤0.01% 2251
2024
Q3 		$325K Buy
+7,647
New +$258K ﹤0.01% 2719
2023
Q1 		– Sell
-3,564
Closed -$31K – 2721
2022
Q4 		$31K Hold
3,564
– – ﹤0.01% 2515
2022
Q3 		$103K Sell
3,564
-762
-18% -$34.9K ﹤0.01% 2684
2022
Q2 		$180K Buy
4,326
+1,647
+61% +$112K ﹤0.01% 2595
2022
Q1 		$271K Hold
2,679
– – ﹤0.01% 2619
2021
Q4 		$394K Buy
+2,679
New +$599K ﹤0.01% 2620

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS AM's WGS Position: Q1 2026 in Review

UBS AM reduced its GeneDx Holdings (WGS) stake by 3.6% in Q1 2026, selling an estimated $849K and leaving 249,432 shares worth $16M. The position accounts for ﹤0.01% of the portfolio, ranked #970.

UBS AM first reported a position in WGS in Q4 2021 and has held it in 12 quarters since. The position peaked at $33.7M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • UBS AM held 249,432 shares of GeneDx Holdings worth $16M as of Q1 2026.
  • UBS AM sold 9,313 GeneDx Holdings shares in Q1 2026, an estimated $849K.
  • GeneDx Holdings made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #970 holding.
  • UBS AM first reported a position in GeneDx Holdings in Q4 2021 and has held it in 12 quarters since.
  • UBS AM's GeneDx Holdings position peaked at $33.7M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.